Xenon Pharmaceuticals
XENE
23 hedge funds and large institutions have $75.2M invested in Xenon Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
35% more funds holding
Funds holding: 17 → 23 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $83.1M → $75.2M (-$7.97M)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.24M |
| 2 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
+$2.54M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.03M |
| 4 |
VAM
Visium Asset Management
New York
|
+$462K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$227K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$4.19M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.99M |
| 3 |
Goldman Sachs
New York
|
-$163K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$158K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$81.3K |
XENE Hedge Fund Activity: Q1 2015 in Review
23 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Xenon Pharmaceuticals (XENE) for Q1 2015, worth a combined $75.2M — down 9.6% from $83.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new XENE positions and 1 closed out — a net gain of 6 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $4.24M. The largest seller was BVF Inc, cutting an estimated $4.19M.
- 23 institutional investors held Xenon Pharmaceuticals (XENE) as of Q1 2015, up from 17 in Q4 2014.
- Funds reported $75.2M of Xenon Pharmaceuticals stock for Q1 2015, down 9.6% quarter-over-quarter.
- 7 funds opened new Xenon Pharmaceuticals positions in Q1 2015 and 1 closed out, a net change of +6 holders.
- The largest Xenon Pharmaceuticals buyer in Q1 2015 was Royal Bank of Canada, an estimated $4.24M added.
- The largest Xenon Pharmaceuticals seller in Q1 2015 was BVF Inc, an estimated $4.19M sold.
Based on aggregated 13F filings for Q1 2015.